Literature DB >> 28771670

Clarithromycin as a "repurposing drug" against MALT lymphoma.

Andrés J M Ferreri1, Caterina Cecchetti1, Barbara Kiesewetter2, Marianna Sassone1, Teresa Calimeri1, Salvatore Perrone1, Maurilio Ponzoni3, Markus Raderer2.   

Abstract

Entities:  

Keywords:  MALT lymphoma; clarithromycin; indolent lymphomas; repurposing drugs

Mesh：

Substances：

Year:  2017        PMID： 28771670     DOI： 10.1111/bjh.14878

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  8 in total

Review 1.  Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming Perspectives.

Authors:  Dominic Kaddu-Mulindwa; Lorenz Thurner; Konstantinos Christofyllakis; Moritz Bewarder; Igor Age Kos
Journal:  Cancers (Basel)       Date:  2022-06-19       Impact factor: 6.575

Review 2.  How I treat MALT lymphoma: 'a subjective interpretation of the gospel according to Isaacson….'

Authors:  Markus Raderer; Barbara Kiesewetter
Journal:  ESMO Open       Date:  2020-07

3.  Treatment of mucosa associated lymphoid tissue lymphoma with a long-term once-weekly regimen of oral azithromycin: Results from the phase II MALT-A trial.

Authors:  Heimo Lagler; Barbara Kiesewetter; Werner Dolak; Markus Obermueller; Ingrid Simonitsch-Klupp; Julius Lukas; Ortrun Neuper; Wolfgang W Lamm; Marius E Mayerhoefer; Markus Raderer
Journal:  Hematol Oncol       Date:  2018-09-19       Impact factor: 5.271

4.  First Line Systemic Treatment for MALT Lymphoma-Do We Still Need Chemotherapy? Real World Data from the Medical University Vienna.

Authors:  Barbara Kiesewetter; Ingrid Simonitsch-Klupp; Marius E Mayerhoefer; Werner Dolak; Julius Lukas; Markus Raderer
Journal:  Cancers (Basel)       Date:  2020-11-26       Impact factor: 6.639

Review 5.  Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy.

Authors:  Verena Hofschröer; Karolina Najder; Micol Rugi; Rayhana Bouazzi; Marco Cozzolino; Annarosa Arcangeli; Gyorgy Panyi; Albrecht Schwab
Journal:  Front Pharmacol       Date:  2021-01-19       Impact factor: 5.810

Review 6.  Current Status of the Spectrum and Therapeutics of Helicobacter pylori-Negative Mucosa-Associated Lymphoid Tissue Lymphoma.

Authors:  Sung-Hsin Kuo; Kun-Huei Yeh; Chung-Wu Lin; Jyh-Ming Liou; Ming-Shiang Wu; Li-Tzong Chen; Ann-Lii Cheng
Journal:  Cancers (Basel)       Date:  2022-02-16       Impact factor: 6.639

Review 7.  Extranodal Marginal Zone Lymphoma: Pathogenesis, Diagnosis and Treatment.

Authors:  Alice Di Rocco; Luigi Petrucci; Giovanni Manfredi Assanto; Maurizio Martelli; Alessandro Pulsoni
Journal:  Cancers (Basel)       Date:  2022-03-29       Impact factor: 6.639

Review 8.  Impact of the microenvironment on the pathogenesis of mucosa-associated lymphoid tissue lymphomas.

Authors:  Barbara Uhl; Katharina T Prochazka; Karoline Fechter; Katrin Pansy; Hildegard T Greinix; Peter Neumeister; Alexander Ja Deutsch
Journal:  World J Gastrointest Oncol       Date:  2022-01-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.